Publicaciones en las que colabora con Vicente Felipo Orts (24)

2022

  1. Metabolic syndrome is associated with poor response to rifaximin in minimal hepatic encephalopathy

    Scientific Reports, Vol. 12, Núm. 1

2018

  1. Cirrhotic patients with minimal hepatic encephalopathy have increased capacity to eliminate superoxide and peroxynitrite in lymphocytes, associated with cognitive impairment

    Free Radical Research, Vol. 52, Núm. 1, pp. 118-133

  2. Learning and Memory Impairments in Patients with Minimal Hepatic Encephalopathy are Associated with Structural and Functional Connectivity Alterations in Hippocampus

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Altered postural control and stability in cirrhotic patients with minimal hepatic encephalopathy correlate with cognitive deficits

    Liver International, Vol. 37, Núm. 7, pp. 1013-1022

  2. Minimal hepatic encephalopathy is associated with expansion and activation of CD4+CD28-, Th22 and Tfh and B lymphocytes

    Scientific Reports, Vol. 7, Núm. 1

  3. Reduced resting state connectivity and gray matter volume correlate with cognitive impairment in minimal hepatic encephalopathy

    PLoS ONE, Vol. 12, Núm. 10

  4. The PHES battery does not detect all cirrhotic patients with early neurological deficits, which are different in different patients

    PLoS ONE, Vol. 12, Núm. 2

2015

  1. Is Cognitive Impairment in Cirrhotic Patients Due to Increased Peroxynitrite and Oxidative Stress?

    Antioxidants and Redox Signaling, Vol. 22, Núm. 10, pp. 871-877

2014

  1. Non invasive blood flow measurement in cerebellum detects minimal hepatic encephalopathy earlier than psychometric tests

    World Journal of Gastroenterology, Vol. 20, Núm. 33, pp. 11815-11825

  2. Reduced white matter microstructural integrity correlates with cognitive deficits in minimal hepatic encephalopathy

    Gut

2013

  1. Serum nitrotyrosine and psychometric tests as indicators of impaired fitness to drive in cirrhotic patients with minimal hepatic encephalopathy

    Liver International, Vol. 33, Núm. 10, pp. 1478-1489

2012

  1. Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy

    Metabolic Brain Disease, Vol. 27, Núm. 1, pp. 51-58

  2. Focal cortical damage parallels cognitive impairment in minimal hepatic encephalopathy

    NeuroImage, Vol. 61, Núm. 4, pp. 1165-1175

  3. Patients with minimal hepatic encephalopathy show impaired mismatch negativity correlating with reduced performance in attention tests

    Hepatology, Vol. 55, Núm. 2, pp. 530-539

2011

  1. 3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis

    American Journal of Gastroenterology, Vol. 106, Núm. 9, pp. 1629-1637

2010

  1. Serum metabolic signature of minimal hepatic encephalopathy by 1H-nuclear magnetic resonance

    Journal of Proteome Research, Vol. 9, Núm. 10, pp. 5180-5187

2009

  1. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy

    Journal of Clinical Gastroenterology, Vol. 43, Núm. 3, pp. 272-279

2007

  1. A single transient episode of hyperammonemia induces long-lasting alterations in protein kinase A

    American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 292, Núm. 1

  2. Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients

    Journal of Molecular Medicine, Vol. 85, Núm. 3, pp. 233-241

2005

  1. Correlation of nitric oxide and atrial natriuretic peptide changes with altered cGMP homeostasis in liver cirrhosis

    Liver International, Vol. 25, Núm. 4, pp. 787-795